DARE BIOSCIENCE, INC.
Profile
Company Names
DARE BIOSCIENCE, INC.
CERULEAN PHARMA INC.
Addresses
3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA 92122
11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA, CA 92037
35 GATEHOUSE DRIVE, WALTHAM, MA 02451
840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE, MA 02139
161 FIRST STREET, CAMBRIDGE, MA 02142
Phone Numbers
858-926-7655
858-769-9145
781-996-4300
617-551-9600
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2005
State Incorporated:
DELAWARE
Total Amount Raised:
$86,969,972.00
Number of Funding Rounds:
11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2024-10-21
$0.00
$15,000,000.00
$15,000,000.00
Equity
10
2023-12-21
$1,733,500.00
$4,160,400.00
$2,426,900.00
9
2019-11-20
$3,544,992.00
$3,544,992.00
$0.00
Equity
8
2017-07-19
$20,691,388.00
$20,691,388.00
$0.00
Equity
7
2016-10-04
$1.00
$1.00
$0.00
6
2012-11-30
$13,000,000.00
$13,000,000.00
$0.00
Equity
5
2011-12-02
$15,000,098.00
$15,000,098.00
$0.00
Equity
4
2010-11-12
$16,499,994.00
$23,999,989.00
$7,499,995.00
Equity
3
2010-09-29
$1,499,999.00
$1,499,999.00
$0.00
Debt
2
2010-05-26
$5,000,000.00
$5,000,000.00
$0.00
Debt
1
2009-07-13
$10,000,000.00
$10,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGG
BELOFF
EXECUTIVE OFFICER
CHERYL
BLANCHARD
DIRECTOR
CHERYL
R.
BLANCHARD
DIRECTOR
ALAN
CRANE
DIRECTOR
CERULEAN PHARMA INC.
| PARASOL THERAPEUTICS INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| VISTERRA, INC.
| EXPERIMENT FUND, LLC
| OCULAR THERAPEUTIX, INC
| CALORICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| PANDION THERAPEUTICS, INC.
| SEISMIC THERAPEUTIC, INC.
ALAN
L.
CRANE
DIRECTOR
ALEXANDRA
GLUCKSMANN
EXECUTIVE OFFICER
CHRISTOPHER
D.T.
GUIFFRE
EXECUTIVE OFFICER, DIRECTOR
SABRINA
MARTUCCI
JOHNSON
EXECUTIVE OFFICER, DIRECTOR
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
TERRY
MCGUIRE
DIRECTOR
ROBERT
PAULL
DIRECTOR
WILLIAM
H.
RASTETTER
DIRECTOR
BRYAN
E.
ROBERTS
DIRECTOR
CERULEAN PHARMA INC.
| IRONWOOD PHARMACEUTICALS INC
| IKARIA HOLDINGS INC
| FATE THERAPEUTICS INC
| ACHAOGEN INC
| VENROCK ASSOCIATES VI, L.P.
| VENROCK PARTNERS VI, L.P.
| VENROCK ASSOCIATES VII, L.P.
| VENROCK ASSOCIATES VIII, L.P.
| VENROCK ASSOCIATES IX, L.P.
| VENROCK ASSOCIATES X, L.P.
| VENROCK PARTNERS X, L.P.
JOHN
RYAN
EXECUTIVE OFFICER
GOLD CREST MINES INC
| MARKET SCIENCE, INC.
| DESERT HAWK GOLD CORP.
| VERTOS MEDICAL INC
| FP TECHNOLOGY
| CERULEAN PHARMA INC.
| VALERITAS INC
| FLEXENERGY, INC.
| KADMON HOLDINGS, LLC
| SHOSHONE SILVER/GOLD MINING CO
| NEVADA EXPLORATION INC
| FPSI, INC.
| IPR INTERNATIONAL LLC
| PREMIUM EXPLORATION INC
| RELIEVANT MEDSYSTEMS INC
| CIT GROUP INC
| GLOBAVIR BIOSCIENCES INC.
| IPRSECURE, LLC
| UNICYCIVE THERAPEUTICS, INC.
| GOLD EXPRESS MINES, INC.
| GRYPHON ENVIRONMENTAL LLC
| ENCINA CAPITAL GROUP, LLC
| ENCINA LENDER FINANCE, LLC
| ENCINA LENDER FINANCE INTERMEDIATE SPV, LLC
| LIGHTNING CREEK RESOURCES CORP
| KEY METALS CORP.
| YELLOW BAND OPERATING LLC
| ENCINA PRIVATE CREDIT INTERMEDIATE HOLDCO, LLC
| ENCINA PRIVATE CREDIT HOLDCO, LLC
| KARMANTERRA LLC
| KEY MINING CORP.
ROBIN
STEELE
DIRECTOR
ROBERT
TEPPER
DIRECTOR
CERULEAN PHARMA INC.
| ALNARA PHARMACEUTICALS INC
| CONSTELLATION PHARMACEUTICALS INC
| FOUNDATION MEDICINE, INC.
| KALA PHARMACEUTICALS, INC.
| BLUEBIRD BIO, INC.
| THIRD ROCK VENTURES III, L.P.
| ALLENA PHARMACEUTICALS, INC.
| JOUNCE THERAPEUTICS, INC.
| THIRD ROCK VENTURES IV, L.P.
| NEON THERAPEUTICS, INC.
| THIRD ROCK VENTURES V, L.P.
| FAZE MEDICINES, INC.
| THIRD ROCK VENTURES VI, L.P.
DAVID
R.
WALT
DIRECTOR
LISA
WALTERS-HOFFERT
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-10-21
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-07-19
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

